{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:58:33Z","timestamp":1790488713714,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea (NRF)","doi-asserted-by":"crossref","award":["2012-00011"],"award-info":[{"award-number":["2012-00011"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Korean government (MEST)"},{"name":"Gyeonggi-do and KISTI"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.exppara.2013.03.022","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T17:42:41Z","timestamp":1364492561000},"page":"235-243","source":"Crossref","is-referenced-by-count":20,"title":["Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites"],"prefix":"10.1016","volume":"134","author":[{"given":"Laura M.","family":"Alcantara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina B.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio H.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin D.","family":"Franzoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukjun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio H.","family":"Freitas-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Ayong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2013.03.022_b0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0006-2952(97)00482-6","article-title":"Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum","volume":"55","author":"Adovelande","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exppara.2013.03.022_b0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2958.2005.04556.x","article-title":"Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance","volume":"56","author":"Bray","year":"2005","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.exppara.2013.03.022_b0015","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","article-title":"Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)\/ABCG2 drug pump","volume":"104","author":"Burger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exppara.2013.03.022_b0020","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1021\/bi901034r","article-title":"Chloroquine transport in Plasmodium falciparum. 1. Influx and efflux kinetics for live trophozoite parasites using a novel fluorescent chloroquine probe","volume":"48","author":"Cabrera","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.exppara.2013.03.022_b0025","doi-asserted-by":"crossref","first-page":"11152","DOI":"10.1021\/bi901765v","article-title":"Reduced digestive vacuolar accumulation of chloroquine is not linked to resistance to chloroquine toxicity","volume":"48","author":"Cabrera","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.exppara.2013.03.022_b0030","doi-asserted-by":"crossref","first-page":"e4551","DOI":"10.1371\/journal.pone.0004551","article-title":"Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment","volume":"4","author":"Carrara","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2013.03.022_b0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou\u2013Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.exppara.2013.03.022_b0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0169-4758(91)90197-V","article-title":"The P-glycoprotein homologues of Plasmodium falciparum: are they involved in chloroquine resistance?","volume":"7","author":"Cowman","year":"1991","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.exppara.2013.03.022_b0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exppara.2013.03.022_b0050","doi-asserted-by":"crossref","unstructured":"Eechoute, K., Sparreboom, A., Burger, H., Franke, R.M., Schiavon, G., Verweij, J., Loos, W.J., Wiemer, E.A., Mathijssen, R.H., 2011. Drug transporters and imatinib treatment: implications for clinical practice. Clin. Cancer Res. 17, 406\u2013415.","DOI":"10.1158\/1078-0432.CCR-10-2250"},{"key":"10.1016\/j.exppara.2013.03.022_b0055","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1158\/0008-5472.CAN-04-3303","article-title":"Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib)","volume":"65","author":"Elkind","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.exppara.2013.03.022_b0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0006-2952(01)00878-4","article-title":"Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes","volume":"63","author":"Famin","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exppara.2013.03.022_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00249-8","article-title":"Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum","volume":"110","author":"Fidock","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2013.03.022_b0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2174\/138945006778019372","article-title":"Chloroquine resistance reversal agents as promising antimalarial drugs","volume":"7","author":"Henry","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.exppara.2013.03.022_b0075","first-page":"24","article-title":"Drugs for malaria: something old, something new, something borrowed","volume":"3","author":"Hobbs","year":"2009","journal-title":"F1000 Biol. Rep."},{"key":"10.1016\/j.exppara.2013.03.022_b0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.exppara.2008.10.008","article-title":"Plasmodium falciparum: development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer","volume":"121","author":"Izumiyama","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.03.022_b0085","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1128\/AAC.00669-07","article-title":"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum","volume":"51","author":"Kelly","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2013.03.022_b0090","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.1104063108","article-title":"Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion","volume":"108","author":"Klonis","year":"2011","journal-title":"Proc. Natl. Acad. Sci. US A"},{"key":"10.1016\/j.exppara.2013.03.022_b0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.pt.2010.05.002","article-title":"The ABCs of multidrug resistance in malaria","volume":"26","author":"Koenderink","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2013.03.022_b0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcp.2009.08.021","article-title":"Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance","volume":"79","author":"Kuang","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exppara.2013.03.022_b0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0854.2009.01018.x","article-title":"Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum","volume":"11","author":"Kuhn","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.exppara.2013.03.022_b0110","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1038\/sj.emboj.7600681","article-title":"A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance","volume":"24","author":"Lakshmanan","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.exppara.2013.03.022_b0115","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2013.03.022_b0120","doi-asserted-by":"crossref","unstructured":"Lehane, A.M., McDevitt, C.A., Kirk, K., Fidock, D.A., Degrees of chloroquine resistance in Plasmodium \u2013 is the redox system involved? Int. J. Parasitol. Drugs Drug Resist. 2, 47\u201357.","DOI":"10.1016\/j.ijpddr.2011.11.001"},{"key":"10.1016\/j.exppara.2013.03.022_b0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1751-1097.1991.tb02028.x","article-title":"Time-resolved fluorescence of nitrobenzoxadiazole-aminohexanoic acid: effect of intermolecular hydrogen-bonding on non-radiative decay","volume":"54","author":"Lin","year":"1991","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.exppara.2013.03.022_b0130","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.1175667","article-title":"Chloroquine transport via the malaria parasite\u2019s chloroquine resistance transporter","volume":"325","author":"Martin","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.exppara.2013.03.022_b0135","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1128\/AAC.01689-08","article-title":"In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid","volume":"53","author":"Masseno","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2013.03.022_b0140","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0020-7519(02)00194-7","article-title":"Artemisinin: mechanisms of action, resistance and toxicity","volume":"32","author":"Meshnick","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2013.03.022_b0145","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1365-2958.2003.03627.x","article-title":"Multiple transporters associated with malaria parasite responses to chloroquine and quinine","volume":"49","author":"Mu","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.exppara.2013.03.022_b0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","article-title":"Global malaria mortality between 1980 and 2010: a systematic analysis","volume":"379","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2013.03.022_b0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.parint.2005.11.058","article-title":"Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro","volume":"55","author":"Nakornchai","year":"2006","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2013.03.022_b0160","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The molecular mechanism of action of artemisinin \u2013 the debate continues","volume":"15","author":"O\u2019Neill","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.exppara.2013.03.022_b0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drup.2005.02.002","article-title":"Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters","volume":"8","author":"Ozvegy-Laczka","year":"2005","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.exppara.2013.03.022_b0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijpharm.2011.05.082","article-title":"Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes","volume":"416","author":"Patel","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2013.03.022_b0175","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0140-6736(89)90522-9","article-title":"Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum","volume":"2","author":"Peters","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2013.03.022_b0180","doi-asserted-by":"crossref","unstructured":"Petersen, I., Eastman, R., Lanzer, M., 2011. Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett 585, 1551\u20131562.","DOI":"10.1016\/j.febslet.2011.04.042"},{"key":"10.1016\/j.exppara.2013.03.022_b0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2875-8-89","article-title":"A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria","volume":"8","author":"Picot","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.exppara.2013.03.022_b0190","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1074\/jbc.M806944200","article-title":"Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione","volume":"284","author":"Raj","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2013.03.022_b0195","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01478-07","article-title":"Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum","volume":"52","author":"Roberts","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2013.03.022_b0200","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/sj.emboj.7601203","article-title":"Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum","volume":"25","author":"Rohrbach","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.exppara.2013.03.022_b0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/expr.1994.1073","article-title":"Plasmodium falciparum: the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite","volume":"79","author":"Rubio","year":"1994","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.03.022_b0210","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijpara.2010.04.001","article-title":"Transporters as mediators of drug resistance in Plasmodium falciparum","volume":"40","author":"Sanchez","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2013.03.022_b0215","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2958.2008.06413.x","article-title":"Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum","volume":"70","author":"Sanchez","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.exppara.2013.03.022_b0220","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pt.2007.04.013","article-title":"Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum","volume":"23","author":"Sanchez","year":"2007","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2013.03.022_b0225","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3201\/eid1410.080080","article-title":"Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia","volume":"14","author":"Shah","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.exppara.2013.03.022_b0230","doi-asserted-by":"crossref","first-page":"e7520","DOI":"10.1371\/journal.pone.0007520","article-title":"Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10)","volume":"4","author":"Shen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2013.03.022_b0235","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/507115","article-title":"Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin","volume":"194","author":"Sidhu","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2013.03.022_b0240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-3156.1998.00212.x","article-title":"Enhancement of the antimalarial effect of chloroquine by chloropheniramine in vivo","volume":"3","author":"Sowunmi","year":"1998","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.exppara.2013.03.022_b0245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0049-3848(94)90197-X","article-title":"Fluorescence studies on plasminogen activator inhibitor 1: reactive centre cysteine mutants remain active after fluorophore attachment","volume":"76","author":"Strandberg","year":"1994","journal-title":"Thromb. Res."},{"key":"10.1016\/j.exppara.2013.03.022_b0250","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4161\/viru.1.4.12012","article-title":"Functional characteristics of the malaria parasite\u2019s \u201cchloroquine resistance transporter\u201d: implications for chemotherapy","volume":"1","author":"Summers","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.exppara.2013.03.022_b0255","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1021\/jm049065t","article-title":"Transmembrane inhibitors of P-glycoprotein, an ABC transporter","volume":"48","author":"Tarasova","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2013.03.022_b0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.exppara.2013.03.022_b0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drup.2006.09.002","article-title":"Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum","volume":"9","author":"van Schalkwyk","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.exppara.2013.03.022_b0270","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/345253a0","article-title":"Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross","volume":"345","author":"Wellems","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.exppara.2013.03.022_b0275","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3201\/eid1405.071601","article-title":"Declining artesunate\u2013mefloquine efficacy against falciparum malaria on the Cambodia\u2013Thailand border","volume":"14","author":"Wongsrichanalai","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.exppara.2013.03.022_b0280","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1158\/0008-5472.CAN-05-0641","article-title":"Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489413000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489413000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T03:25:46Z","timestamp":1715138746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489413000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0014489413000921"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2013.03.022","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}